P-006 - COMPARISON OF UTOMILUMAB IMMUNOGENICITY IN PATIENTS WITH ADVANCED CANCER.

J. Albanez¹, A. McPhee², I. Salageanu³, Y. Chen¹; ¹Pfizer Inc., San Diego, CA, USA, ²Pfizer Inc., Andover, MA, USA, ³Pfizer Inc., Groton, CT, USA.

Presenting Author(s)

Julia Albanez, BA

Student Pharmacist
Pfizer Inc.
La Jolla, California, United States